Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Endocrinology|December 1, 2023
Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN networkMarine Perrier, Mathias Brugel, Laura Gérard, et al.
Cancer Treatment Reviews|June 4, 2025
Medical management of pancreatic cancer: from personalization to broadening treatment strategiesNelson Dusetti, Jean Baptiste Bachet, Brice Chanez, et al.
Neuroendocrinology|September 4, 2015
Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine TumorsJerome Cros, Emilie Moati, Jerome Raffenne, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 14, 2019
The ENETS TNM staging and grading system accurately predict prognosis in patients with rectal NENsGabriele Capurso, Sebastien Gaujoux, Lorenzo Carlo Pescatori, et al.
Radiology. Imaging Cancer|January 6, 2023
Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial TreatmentJessica Assouline, Roberto Cannella, Giorgia Porrello, et al.
The Journal of Pathology|February 12, 2025
Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom-up approachMarc Hilmi, Flore Delecourt, Jérôme Raffenne, et al.
The British Journal of Surgery|November 29, 2024
Mural nodules and prevalence of high-grade dysplasia in branch duct intraductal papillary mucinous neoplasm of the pancreas undergoing resectionDiane Lorenzo, Lina Aguilera Munoz, Anne-Laure Vedie, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2024
Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN NetworkLaure Al Mansour, Louis De Mestier, Magalie Haissaguerre, et al.
Neuroendocrinology|February 14, 2019
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score AnalysesLouis de Mestier, Thomas Walter, Hedia Brixi, et al.
Scientific Reports|August 30, 2025
Selective right heart valve remodelling in a mouse model of carcinoid disease revealed by high-resolution episcopic microscopyGaspard Suc, Mustafa Habib, Sofiane Mohammed, et al.
Pageof 13